Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Blonda

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|May 31, 2021
How to Value Orphan Drugs? A Review of European Value Assessment FrameworksAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.
Frontiers in Pharmacology|February 7, 2022
Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European CountriesAlessandra Blonda, Teresa Barcina Lacosta, Mondher Toumi, et al.
Frontiers in Pharmacology|August 5, 2022
How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European CountriesAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.
Health Affairs (Project Hope)|August 4, 2025
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price NegotiationsDaniel A Ollendorf, Leah Z Rand, Alessandra Blonda, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 17, 2025
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-centred Decision-Making in HealthcareElise Schoefs, Alice Vanneste, Alessandra Blonda, et al.
Frontiers in Pharmacology|October 3, 2022
How to balance valuable innovation with affordable access to medicines in Belgium?Steven Simoens, Khadidja Abdallah, Liese Barbier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|May 31, 2021
How to Value Orphan Drugs? A Review of European Value Assessment FrameworksAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.
Frontiers in Pharmacology|February 7, 2022
Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European CountriesAlessandra Blonda, Teresa Barcina Lacosta, Mondher Toumi, et al.
Frontiers in Pharmacology|August 5, 2022
How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European CountriesAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.
Health Affairs (Project Hope)|August 4, 2025
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price NegotiationsDaniel A Ollendorf, Leah Z Rand, Alessandra Blonda, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 17, 2025
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-centred Decision-Making in HealthcareElise Schoefs, Alice Vanneste, Alessandra Blonda, et al.
Frontiers in Pharmacology|October 3, 2022
How to balance valuable innovation with affordable access to medicines in Belgium?Steven Simoens, Khadidja Abdallah, Liese Barbier, et al.
Pageof 1